z-logo
Premium
“In‐loop” 18 F‐fluorination: A proof‐of‐concept study
Author(s) -
Dahl Kenneth,
Garcia Armando,
Stephenson Nickeisha A.,
Vasdev Neil
Publication year - 2019
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3751
Subject(s) - chemistry , radiosynthesis , nitrobenzene , radiochemistry , labelling , fluorine , pet imaging , fluoride , combinatorial chemistry , organic chemistry , inorganic chemistry , nuclear medicine , positron emission tomography , catalysis , medicine , biochemistry
There is a great demand to develop more cost‐efficient and robust manufacturing processes for fluorine‐18 ( 18 F) labelled compounds and radiopharmaceuticals. Herein, we present to our knowledge the first radiofluorination “in‐loop,” where [ 18 F]triflyl fluoride was used as the labelling agent. Initial development of the “in‐loop” [ 18 F]fluorination method was optimized by reacting [ 18 F]triflyl fluoride with 1,4‐dinitrobenzene to form [ 18 F]1‐fluoro‐4‐nitrobenzene. This methodology was then applied for the syntheses of two well‐known radiopharmaceuticals, namely, [ 18 F]T807 for imaging of tau protein and [ 18 F]FEPPA for imaging the translocator protein 18 KDa. Both radiotracers were synthesized and formulated using an automated radiosynthesis module with nondecay corrected radiochemical yields of 27% and 29% (relative [ 18 F]F − ), respectively. The overall syntheses times for [ 18 F]T807 and [ 18 F]FEPPA were 65 and 55 minutes, respectively. In these cases, our “in‐loop” radiofluorination methodology enabled us to obtain equal or superior yields compared with conventional reactions in a vial. The radiochemical purities were more than 99%, and the molar activities were more than 350 GBq/μmol at the end‐of‐synthesis for both radiotracers. This novel method is simple, efficient, and allows for a reliable production of radiofluorinated compounds and radiopharmaceuticals.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom